FDA Adverse Event Injury Summary report: N

AMPLATZER® SEPTAL OCCLUDER

MDR report key: 1915178 · Received December 6, 2010

Report

Report Number
2135147-2010-00176
Event Type
Injury
Date Received
December 6, 2010
Date of Event
October 15, 2010
Report Date
December 6, 2010
Manufacturer
AGA MEDICAL CORPORATION
Product Code
MLV
PMA / PMN Number
P000039
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE AMPLATZER SEPTAL OCCLUDER WAS RETURNED TO AGA MEDICAL IN ITS ORIGINAL CONFIGURATION. FOLLOWING DECONTAMINATION, THE DEVICE WAS MEASURED AND THE SIZE WAS CONFIRMED TO MEET DIMENSIONAL SPECIFICATIONS. THE DEVICE WAS EXAMINED MICROSCOPICALLY AND NO DEFECTS WERE OBSERVED. THE DEVICE WAS LOADED AND DEPLOYED FROM A TEST 12F TORQVUE LOADER WITHOUT ANY DEFORMITIES. DURING MANUFACTURING, THIS DEVICE UNDERWENT A SERIES OF INSPECTIONS AND TESTS TO CONFIRM PROPER FUNCTION, INCLUDING A TEST SIMULATING LOADING AND DEPLOYMENT AND VERIFICATION OF DEVICE SIZING. A REVIEW OF MANUFACTURING DOCUMENTATION CONFIRMED THIS DEVICE SUCCESSFULLY COMPLETED THESE TESTS. THE RESULTS OF THIS INVESTIGATION ARE INCONCLUSIVE BECAUSE MEDICAL RECORDS AND IMAGES WERE NOT PROVIDED, THEREFORE, THE CAUSE OF THE EMBOLIZATION REMAINS UNKNOWN.

Description of Event or Problem · 1

ACCORDING TO THE INITIAL INFORMATION RECEIVED, THE PATIENT IMPLANTED WITH THIS 38MM AMPLATZER SEPTAL OCCLUDER (ASO) HAD INSUFFICIENT POSTERIOR (2MM) AND SUPERIOR (4 MM) RIMS. APPROXIMATELY 24 HOURS POST-PROCEDURE, THE ASO EMBOLIZED. THE DEVICE WAS SURGICALLY RETRIEVED AND THE PATIENT'S DEFECT WAS SURGICALLY CLOSED. AGA REQUESTED FURTHER INFORMATION REGARDING THIS CASE, BUT MEDICAL RECORDS AND IMAGES WERE NOT PROVIDED. ECHOCARDIOGRAMS ARE NEEDED TO CONFIRM SIZING AND EVALUATE OTHER PARAMETERS OF THE IMPLANT PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AMPLATZER® SEPTAL OCCLUDER CARDIAC OCCLUSION DEVICE MLV AGA MEDICAL CORPORATION 9-ASD-038 M09C20-23

Patients

Seq Age Sex Outcome Treatment
1 13 YR Required Intervention